Changeflow GovPing Pharma & Drug Safety Registry of clinical studies worldwide
Routine Notice Added Final

Registry of clinical studies worldwide

Favicon for clinicaltrials.gov ClinicalTrials.gov
Detected March 28th, 2026
Email

Summary

ClinicalTrials.gov has announced the registry of clinical studies worldwide, providing a central platform for information on global research. This update aims to enhance transparency and accessibility of clinical trial data for researchers and the public.

What changed

ClinicalTrials.gov, a registry maintained by the U.S. National Library of Medicine, has updated its platform to include a registry of clinical studies worldwide. This initiative aims to centralize information on ongoing and completed research, enhancing global transparency and accessibility of clinical trial data.

This update primarily serves as an informational notice, providing a resource for researchers, healthcare providers, and the public to access a broader spectrum of clinical study information. No immediate compliance actions are required for regulated entities, but it offers a valuable tool for monitoring research trends and identifying potential collaborations or competitive intelligence.

Source document (simplified)

Show glossary

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
ClinicalTrials.gov
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Medical device makers Healthcare providers Researchers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing 6211 Healthcare Providers
Activity scope
Clinical Trial Registration
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Clinical Trials Research

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ClinicalTrials.gov publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.